AACR: Endeavoring to go global, Zai Lab offers reality check on China’s biotech ascent
Since its 2014 founding, Zai Lab has built its business by licensing drugs from Big Pharma, such as GSK’s ovarian cancer med Zejula and Bristol Myers Squibb’s schizophrenia star Cobenfy, and selling them in China. But in the last three years, the company …